User Fee Bill Or Drug Pricing Bill? House Members Makes Both Cases

House passes bill reauthorizing FDA user fee programs via voice vote and makes many other policy changes, but in the process touts the bill's potential to push drug prices lower.

House members were quick to frame FDA user fee reauthorization legislation as one answer to drug pricing problems as they passed the bill July 12.

More from US FDA

More from Agency Leadership